High performance, on-premise genomic analysis solutions 

Providing better insights from data... and turning knowledge into actionable information, fast, using AI technology!

Contact Us

Why choose OmniTier for my genomic analysis?

  • On-premise analysis appliances provide lower cost analysis, greater control over patient data and large, data storage cost-savings.
  • Supports Illumina, MGI Tech, Oxford Nanopore Technology and PacBio sequencing.
  • Two variant callers; higher quality, proprietary, Novos variant caller, as well as standard Broad Institute (GATK) variant caller; SNPs, indels, structural variants, copy number variants and mitochondrial. Identifies more true-positives and returns fewer false-positive variants.
  • Reduces days of secondary analysis and variant interpretation into minutes through automation and AI technology.
  • Built to scale, from analyzing a few exomes up to thousands of whole genomes. Your OmniTier infrastructure can scale up as your analytics volumes grow.
  • End-to-end, easy to use, built-in analysis workflows. Designed for researchers, clinicians and bioinformaticians, rather than IT and software specialists.
  • Targeting medium to high volume clinical research diagnostics and screening; for clinical research only now.
Analysis tools that all researchers, clinicians and bioinformaticians can agree on.

OmniTier Genomic Analysis Appliances*


Designed to meet the needs of…

pill-bottle Pharmaceutical
med-plus Clinical Diagnosis
layers Sequencing Services Providers
reading Academic Researchers
building Government and Public Studies
helix Genomics Data Providers

News & Updates

View All

NCCHD in Japan Demonstrates Improved Diagnostics Rate for Rare Disease Diagnostics using OmniTier’s CompStor® Genomic Analysis Platform

San Jose CA, USA: February 2, 2023 – Benchmark WES re-analysis study with OmniTier’s AI-based variant interpretation platform achieves around a 42% diagnostics rate, a 7% improvement in the average rate for diagnosing rare diseases

Read More

Genomenon and OmniTier Partner to Bring Mastermind’s Evidence Sources to CompStor Insight

Ann Arbor, Michigan – Genomenon®, Inc., an AI-driven genomics company, announced a partnership with OmniTier, which includes integration of the Mastermind® Genomic Search Engine into their on-premises based CompStor Insight® genomics analysis platform.

Read More

OmniTier customers keep control and retain ownership of their genomics data

(BAY AREA, CA, USA: In response to requirements from some competing human genomics analysis providers to allow them certain usage rights over the customer’s data, OmniTier announces that customers using its secondary analysis and variant interpretation appliances, CompStor Novos® and CompStor Insight® keep full control and ownership of all their data.

Read More